Community/Retail

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

How can pharmacists handle the common dilemma of customers who show up after the store has shut its doors for the day?

Why wait until January to take positive steps to improve your life? Dig into at least one of these volumes now to get a boost.

The United States Preventive Services Task Force (USPSTF) has issued an updated draft recommendation statement on osteoporosis screening to prevent fractures.

A newly-updated clinical guideline provides recommendations on the best types and amounts of medications to treat seasonal allergic rhinitis (SAR).

With the odds of getting into a program just a little better than 1 in 2, how can students make sure that they are successful?

Contrary to what many believe, focusing on the negative can provide a path to success.

Ears are self-cleaning, but there are times when a blockage needs to be cleared. Here is a safe and effective at-home method to try.

State and local marijuana laws continue to evolve toward legalization much faster than the scientific community can collect the data to help society weigh the health, safety, and ethical ramifications of these new laws.

Canagliflozin (Invokana, Janssen) improved renal outcomes and demonstrated potential renal protective effects, according to additional analyses from the CANVAS clinical trial presented at the American Society of Nephrology Kidney Week 2017 Annual Meeting.

The findings demonstrated that female gender, older age, and Caucasian race were the most likely predictors of opioid use in patients with JFMS.

Patients with rheumatoid arthritis (RA) who took biologics or triple therapy had a longer fail time than patients who took methotrexate oral monotherapy, suggesting that these treatments may be a good follow-up to failed first-line methotrexate treatment.

Officials with the FDA have extended the approval of vemurafenib (Zelboraf, Genentech) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare blood cancer, making it the first approved treatment for ECD.

In this clip, Kathy Campbell, PharmD, CEO of Medicap Pharmacy, discusses the benefits of interacting with patients about their wellness and offering weight management services in the pharmacy.

Focus on these 5 mental mantras and watch your community pharmacy practice improve like no other.

Meant as a curricular assessment, this test could hurt colleges and students unexpectedly

David DeRemer, PharmD, Assistant Director of Clinical Therapeutics and Incubator, Clinical Associate Professor at the University of Florida College of Pharmacy, discusses resources to help educate patients on oral chemotherapy agents.

Pharmacy Times took to social media this October to celebrate American Pharmacists Month with our annual #ThankAPharmacist campaign. Here are the 10 noteworthy posts from Facebook, Twitter, and Instagram using the hashtag.

Even beyond American Pharmacists Month, pharmacists deserve to be recognized for the important role they play in patient care.